🇺🇸
United States · US · US:18657-117_37c02d08-e964-4065-ba96-69fe8eed5c2e
HYLENEX Recombinant
UNIISPL
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerAntares Pharma, Inc.
CountryUS (United States)
ATC code—
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc1118657117044 BOX in 1 CARTON (18657-117-04) / 1 VIAL in 1 BOX (18657-117-02) / 1 mL in 1 VIAL (18657-117-01)
Annotations
UNII (FDA Substance ID)
743QUY4VD8
HYALURONIDASE (HUMAN RECOMBINANT)
RxCUI 1300478
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "743QUY4VD8",
"rxcui": "1300478",
"inchikey": null,
"display_name": "HYALURONIDASE (HUMAN RECOMBINANT)",
"substance_type": "protein",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "SUBCUTANEOUS",
"spl_meta": {
"3023cc56-ed4b-4e87-b3a1-81b20943f658": {
"match": "brand_token",
"title": "HYLENEX RECOMBINANT (HYALURONIDASE) INJECTION, SOLUTION [ANTARES PHARMA, INC.]",
"spl_version": "11",
"published_date": "2025-04-23"
}
},
"productid": "18657-117_37c02d08-e964-4065-ba96-69fe8eed5c2e",
"productndc": "18657-117",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "HYALURONIDASE (HUMAN RECOMBINANT)",
"proprietary_name": "HYLENEX Recombinant",
"active_ingred_unit": "[USP'U]/mL",
"application_number": "BLA021859",
"marketing_category": "BLA",
"nonproprietary_name": "Hyaluronidase",
"start_marketing_date": "20051202",
"active_numerator_strength": "150"
}Access this data programmatically
Query HYLENEX Recombinant and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.